Structural analysis of doxorubicin-polymer conjugates

被引:24
作者
Sanyakamdhorn, S. [1 ]
Bekale, L. [1 ]
Agudelo, D. [1 ]
Tajmir-Riahi, H. A. [1 ]
机构
[1] Univ Quebec Trois Rivieres, Dept Chem Biochem & Phys, Trois Rivieres, PQ G9A 5H7, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
PEG; Dendrimer; Drug delivery; Encapsulation; Spectroscopy; TEM; Modeling; POLYAMIDOAMINE DENDRIMERS; POLY(ETHYLENE GLYCOL); STARBURST DENDRIMERS; TARGETED DELIVERY; DRUG; BINDING; ENCAPSULATION; THERAPEUTICS; MICELLES; RELEASE;
D O I
10.1016/j.colsurfb.2015.07.070
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Synthetic polymers poly(ethylene glycol) (PEG), methoxypoly (ethylene glycol) polyamidoamine (mPEG-PAMAM-G3) and polyamidoamine (PAMAM-G4) dendrimers were used for encapsulation of antibiotic drug doxorubicin (Dox) and its analogue N-(trifluoroacetyl)doxorubicin (FDox) in aqueous solution at pH 7.4. Multiple spectroscopic methods, transmission electron microscopy (TEM) and molecular modeling were used to characterize the drug binding process to synthetic polymers. Structural analysis showed that drug-polymer binding occurs via both H-bonding and hydrophobic contacts. The order of binding is PAMAM-G4 > mPEG-PAMAM-G3 > PEG-6000 with Dox forming more stable conjugate than FDox. Transmission electron microscopy showed significant changes in carrier morphology with major changes in the shape of the polymer aggregate as drug encapsulation occurred. Modeling also showed that drug is located in the surface and in the internal cavities of PAMAM with the free binding energy of -4.14 kcal/mol for Dox and -3.93 kcal/mol for FDox, indicating of spontaneous drug polymer-interaction at room temperature. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 41 条
[1]   SYNTHESIS AND PRELIMINARY ANTI-TUMOR EVALUATION OF 5-IMINODOXORUBICIN [J].
ACTON, EM ;
TONG, GL .
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (06) :669-673
[2]   Dendrimeric micelles for controlled drug release and targeted delivery [J].
Ambade, Ashootosh V. ;
Savariar, Elamprakash N. ;
Thayumanavan, S. .
MOLECULAR PHARMACEUTICS, 2005, 2 (04) :264-272
[3]  
[Anonymous], 2013, ADV CHEM ENG SCI
[4]   SYNTHESIS OF NEW N-(TRIFLUOROACETYL)DOXORUBICIN ANALOGS [J].
BERUBE, G ;
RICHARDSON, VJ ;
FORD, CHJ .
SYNTHETIC COMMUNICATIONS, 1991, 21 (07) :931-944
[5]   Investigation of the interaction between flavonoids and human serum albumin [J].
Bi, SY ;
Ding, L ;
Tian, Y ;
Song, DQ ;
Zhou, X ;
Liu, X ;
Zhang, HQ .
JOURNAL OF MOLECULAR STRUCTURE, 2004, 703 (1-3) :37-45
[6]   Super-hydrophilic zwitterionic poly(carboxybetaine) and amphiphilic non-ionic poly(ethylene glycol) for stealth nanoparticles [J].
Cao, Zhiqiang ;
Jiang, Shaoyi .
NANO TODAY, 2012, 7 (05) :404-413
[7]   Doxorubicin: The Good, the Bad and the Ugly Effect [J].
Carvalho, Cristina ;
Santos, Renato X. ;
Cardoso, Susana ;
Correia, Sonia ;
Oliveira, Paulo J. ;
Santos, Maria S. ;
Moreira, Paula I. .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (25) :3267-3285
[8]   Dendrimer-Doxorubicin conjugate for enhanced therapeutic effects for cancer [J].
Chandra, Sudeshna ;
Dietrich, Sascha ;
Lang, Heinrich ;
Bahadur, D. .
JOURNAL OF MATERIALS CHEMISTRY, 2011, 21 (15) :5729-5737
[9]   Effect of synthetic polymers on polymer-protein interaction [J].
Chanphai, Penprapa ;
Bekale, Laurent ;
Sanyakamdhorn, Sriwanna ;
Agudelo, Daniel ;
Tajmir-Riahi, Heidar-Ali .
POLYMER, 2014, 55 (02) :572-582
[10]   A Strategy in The Design of Micellar Shape for Cancer Therapy [J].
Chen, Tao ;
Guo, Xing ;
Liu, Xian ;
Shi, Shuai ;
Wang, Jie ;
Shi, Chunli ;
Qian, Zhiyong ;
Zhou, Shaobing .
ADVANCED HEALTHCARE MATERIALS, 2012, 1 (02) :214-224